1. P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY. (5th April 2022) Authors: Einsele, H; Cohen, AD; Delforge, M; Hillengass, J; Goldschmidt, H; Weisel, K; Raab, M-S; Scheid, C; Schecter, JM; De Braganca, KC; Varsos, H; Yeh, T-M; Wang, L; Vogel, M; Corsale, C; Akram, M; Pacaud, L; Nesheiwat, T; Agha, M; Cohen, YC Journal: HemaSphere Issue: Volume 6(2022)Supplement 2 Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P01.18 Metabolic status and immune activation influence clinical outcomes in patients after allogeneic hematopoietic stem cell transplantation. (1st October 2020) Authors: Althoff, K; Leitzke, S; Herling, C; Frenzel, L; Herling, M; Holtick, U; Scheid, C; von Bergwelt-Baildon, M; Theurich, S Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗